WASHINGTON, April 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has concluded that FLUMADINE (rimantadine hydrochloride) 100 mg tablets, manufactured by Sun Pharmaceutical Industries Inc., were not withdrawn from the market due to safety or effectiveness issues. This decision clears the way for continued approval of generic versions of the antiviral drug, which had been discontinued for marketing but remains listed in the FDA's Orange Book under . . .

Click here for more information about our products